Start as
What changed in this atlas, by month, from the dates its records carry.
2026-10-15
2019 ACC/AHA guideline on the primary prevention of CVD
2020 ACC/AHA valvular heart disease guideline
2022 AHA/ACC/HFSA heart failure guideline
2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline
2024 ESC atrial fibrillation guidelines
2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for acute coronary syndromes
2025 AHA Guidelines for CPR and Emergency Cardiovascular Care
2025 ESC/EACTS valvular heart disease guidelines
2026 ACC/AHA multisociety guideline on the management of dyslipidemia
2026 ESC heart failure guidelines
Abbott
ADA/KDIGO 2022 consensus report on diabetes management in CKD
Adult congenital heart disease
AF that causes no symptoms is hard to diagnose
After a heart attack: from the emergency to recovery
Alirocumab
American Association of Cardiovascular and Pulmonary Rehabilitation
American Diabetes Association
Aortic stenosis
Apixaban
Apple
Apple Heart Study
ARISTOTLE
Arrhythmia (heart rhythm problems)
AstraZeneca
Automated external defibrillator (AED)
Bayer
Beta-blockers (drug class)
Blood pressure lowering medicine
Blood thinners (oral anticoagulants) to prevent stroke in AF
BNP and NT-proBNP blood tests
Boehringer Ingelheim
Boston Scientific
Bruce Neal
Cardiac rehabilitation
Cardiac troponin blood test
Cardiopulmonary resuscitation (CPR)
Cardiovascular polypill
Cardiovascular-kidney-metabolic (CKM) health
CARES cardiac arrest registry
Centers for Medicare & Medicaid Services (CMS)
CHAMPION trial
China Salt Substitute and Stroke Study (SSaSS)
COAPT trial
Dabigatran
DANISH
DAPA-CKD: dapagliflozin in chronic kidney disease
Dapagliflozin
DASH eating plan
DASH-Sodium
Deliver AEDs by drone before the ambulance arrives
EARLY TAVR
Edwards Lifesciences
Elecsys Troponin T Gen 5 STAT assay
Eli Lilly and Company
Emergency stenting for ST-elevation heart attack (primary PCI)
EMPA-KIDNEY: empagliflozin in a broad range of chronic kidney disease
Empagliflozin
EMPEROR-Preserved
Estimated 10-year cardiovascular risk
Evolocumab
Evolocumab (Repatha)
Evolut Low Risk trial
FIDELIO-DKD: finerenone and kidney outcomes in type 2 diabetes
Finerenone (Kerendia)
FLOW: semaglutide and kidney outcomes in type 2 diabetes with chronic kidney disease
Four-class medicine regimen in heart failure (guideline-directed medical therapy)
FOURIER (evolocumab in people with cardiovascular disease)
From a high blood pressure reading to stroke prevention
GLP-1 receptor agonists (drug class)
HbA1c blood test
Heart attack (myocardial infarction)
Heart attack warning signs and when to call for help
Heart failure with mildly reduced or preserved ejection fraction
Heart failure with reduced ejection fraction (HFrEF)
Heart valve disease
Heart-healthy living
HeartStart OnSite and Home defibrillators
HF-ACTION
Home-based cardiac rehabilitation
Implantable cardioverter-defibrillator (ICD)
Inclisiran
International Liaison Committee on Resuscitation (ILCOR)
ISCHEMIA (initial invasive or conservative strategy for stable coronary disease)
Judith S. Hochman
KDIGO 2022 guideline for diabetes management in CKD
Kidney and heart protection in diabetes and chronic kidney disease
Kidney Disease: Improving Global Outcomes (KDIGO)
Left atrial appendage occlusion
Left ventricular ejection fraction (LVEF)
Life's Essential 8
Living well with heart disease
Living with a new heart-failure diagnosis
Low participation in cardiac rehabilitation among eligible patients
Many people with hypertension are not diagnosed, treated or controlled
Medical Research Council (United Kingdom)
Mediterranean diet
Medtronic
Melody transcatheter pulmonary valve
Million Hearts
Million Hearts Cardiac Rehabilitation Change Package
Mineralocorticoid receptor antagonists (drug class)
Mintu Turakhia
Mitral regurgitation
National Heart, Lung, and Blood Institute
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Neurological Disorders and Stroke
National Institute on Aging
National Institutes of Health
NICE NG106: chronic heart failure in adults
NICE NG196: atrial fibrillation, diagnosis and management
NICE NG238: cardiovascular disease risk assessment and reduction, including lipid modification
Novartis
Novo Nordisk
Omron Healthcare, Inc.
Omron HEM-907 blood pressure monitor
PARTNER 3 trial
PCSK9 (gene and protein)
Percutaneous coronary intervention (stents)
Physical inactivity
PREDIMED
Preventing heart attack, stroke and heart failure
PROTECT AF
RE-LY
Rhythm control for AF (medicines or catheter ablation)
Rivaroxaban
ROCKET AF
Sacubitril/valsartan (Entresto)
SCD-HeFT
Screen for AF with consumer wearables
SECURE
SELECT: semaglutide and cardiovascular outcomes in overweight or obesity
Semaglutide
SGLT2 inhibitors (drug class)
Statins
Steps after a cardiac arrest outside hospital
STRIDE BP validated device lists
Stroke prevention in atrial fibrillation
Subcutaneous ICD (S-ICD) system
Sudden cardiac arrest
Surgical aortic valve replacement
SURPASS-CVOT: tirzepatide against dulaglutide on major cardiovascular events
Systolic Blood Pressure Intervention Trial (SPRINT)
Temperature control after cardiac arrest
Tirzepatide
Transcatheter aortic valve replacement (TAVR)
Transcatheter edge-to-edge repair (TEER)
TRILUMINATE Pivotal trial
TTM2
Unequal bystander CPR after cardiac arrest in the community
Urine albumin-to-creatinine ratio (UACR)
USPSTF 2021: screening for hypertension in adults
USPSTF 2022: aspirin use to prevent CVD
USPSTF 2022: screening for atrial fibrillation
USPSTF 2022: statin use for primary prevention of CVD in adults
WHO Global report on hypertension: the race against a silent killer (2023)
WHO HEARTS evaluation in Bangladesh
WHO HEARTS technical package
2026-10-14
2024 ESC guidelines on elevated blood pressure and hypertension
2025 AHA/ACC high blood pressure guideline
American Academy of Physician Associates
American Association of Nurse Practitioners
American College of Clinical Pharmacy
American College of Preventive Medicine
American Geriatrics Society
American Medical Association
American Society of Preventive Cardiology
Amplatzer Septal Occluder
Apixaban (Eliquis)
Apple Heart Study results, NEJM 2019
Aspirin
Association of Black Cardiologists
Atrial fibrillation (AF)
Bempedoic acid
CardioMEMS HF System
Centers for Disease Control and Prevention
Chronic kidney disease (CKD)
CLEAR Outcomes (bempedoic acid in statin-intolerant people)
ClinicalTrials.gov
Colchicine
Congenital heart disease
CoreValve and Evolut transcatheter valves
Coronary artery disease
Dabigatran (Pradaxa)
DAPA-HF
Dapagliflozin (Farxiga)
DECLARE-TIMI 58: dapagliflozin and cardiovascular outcomes in type 2 diabetes
DELIVER
Devices and monitoring
Diabetes mellitus
Diagnostics and imaging
Echocardiography
Emergency and acute care
EMPA-REG OUTCOME: empagliflozin and cardiovascular outcomes in type 2 diabetes
Empagliflozin (Jardiance)
EMPEROR-Reduced
Estimated glomerular filtration rate (eGFR)
European Society of Cardiology
Ezetimibe
Finerenone
Heart failure
High LDL cholesterol
IMPROVE-IT (ezetimibe added to simvastatin after acute coronary syndrome)
Inclisiran (Leqvio)
Irregular Rhythm Notification Feature (Apple)
ISCHEMIA main results, NEJM 2020
Kidney and metabolic care
LDL cholesterol blood test
LEADER: liraglutide and cardiovascular events in type 2 diabetes
Lipoprotein(a)
Look AHEAD: intensive lifestyle intervention in type 2 diabetes
Many people with HFrEF do not receive all recommended medicines at target doses
Medicines
MedlinePlus
MitraClip
National Medical Association
Obesity
ODYSSEY OUTCOMES (alirocumab after acute coronary syndrome)
ORION-4 (inclisiran outcome trial)
PARADIGM-HF
Peripartum cardiomyopathy
Prevention and lifestyle
Preventive Cardiovascular Nurses Association
Procedures and surgery
Rehabilitation and living well
Rheumatic heart disease
Rheumatic heart disease burden where prevention and valve surgery are hard to reach
Rivaroxaban (Xarelto)
Sacubitril/valsartan (combination)
SAPIEN 3 transcatheter heart valve
Semaglutide injection for diabetes (Ozempic)
Semaglutide injection for weight management (Wegovy)
Smartwatch irregular-pulse detection
Society of General Internal Medicine
Start and step up heart-failure medicines quickly after a hospital stay
Tirzepatide (Mounjaro)
Tobacco smoking
TriClip
Type 2 diabetes
U.S. Preventive Services Task Force
Use of lower-sodium salt substitutes: WHO guideline (2025)
WATCHMAN left atrial appendage closure device
2026-10-13
Ambulatory blood pressure monitoring (ABPM)
Cuffless blood pressure monitoring
NICE guideline NG136: Hypertension in adults, diagnosis and management
2026-10-12
Acute coronary syndrome not resulting in myocardial infarction (SPRINT component)
Acute decompensated heart failure (SPRINT component)
Death from cardiovascular causes (SPRINT component)
Myocardial infarction (SPRINT component)
National Health and Medical Research Council of Australia
Salt substitution (lower-sodium, potassium-containing salt)
SPRINT primary composite cardiovascular outcome
SSaSS main results, NEJM 2021
World Health Organization
2026-10-11
American College of Cardiology
American Heart Association
Automated upper-arm cuff blood pressure device
Blood pressure
BPLTTC individual-participant meta-analysis, Lancet 2021
High sodium intake
Home blood pressure monitoring
Hypertension treatment by nonphysician professionals, such as pharmacists and nurses
Stroke
Stroke as an outcome
The George Institute for Global Health
The Lancet
U.S. Food and Drug Administration
WHO guideline for the pharmacological treatment of hypertension in adults (2021)
2026-10-09
Blood-pressure lowering to a target
Death from any cause
Hypertension (high blood pressure)
Intensive systolic blood-pressure lowering (target below 120 mm Hg)
National Institute for Health and Care Excellence
SPRINT primary results, NEJM 2015
The New England Journal of Medicine
Wake Forest University Health Sciences
2020 ACC/AHA valvular heart disease guideline 1 claim
2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline 2 claims
2024 ESC atrial fibrillation guidelines 1 claim
2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for acute coronary syndromes 1 claim
2025 AHA Guidelines for CPR and Emergency Cardiovascular Care 1 claim
2026 ACC/AHA multisociety guideline on the management of dyslipidemia 1 claim
2026 ESC heart failure guidelines 1 claim
ADA/KDIGO 2022 consensus report on diabetes management in CKD 4 claims
Aspirin 3 claims
Automated external defibrillator (AED) 1 claim
Beta-blockers (drug class) 1 claim
Blood thinners (oral anticoagulants) to prevent stroke in AF 1 claim
Cardiac rehabilitation 4 claims
Cardiac troponin blood test 1 claim
Cardiopulmonary resuscitation (CPR) 1 claim
Cardiovascular polypill 1 claim
Cardiovascular-kidney-metabolic (CKM) health 1 claim
DASH eating plan 1 claim
Elecsys Troponin T Gen 5 STAT assay 1 claim
Emergency stenting for ST-elevation heart attack (primary PCI) 1 claim
Estimated 10-year cardiovascular risk 1 claim
Finerenone 1 claim
Four-class medicine regimen in heart failure (guideline-directed medical therapy) 1 claim
GLP-1 receptor agonists (drug class) 1 claim
Heart-healthy living 1 claim
HeartStart OnSite and Home defibrillators 1 claim
HF-ACTION 1 claim
Home-based cardiac rehabilitation 1 claim
Implantable cardioverter-defibrillator (ICD) 2 claims
KDIGO 2022 guideline for diabetes management in CKD 1 claim
Left atrial appendage occlusion 1 claim
Life's Essential 8 1 claim
Low participation in cardiac rehabilitation among eligible patients 1 claim
Many people with hypertension are not diagnosed, treated or controlled 1 claim
Mediterranean diet 1 claim
Million Hearts 1 claim
Million Hearts Cardiac Rehabilitation Change Package 1 claim
Physical inactivity 2 claims
Sacubitril/valsartan (combination) 1 claim
SGLT2 inhibitors (drug class) 2 claims
Statins 4 claims
Subcutaneous ICD (S-ICD) system 1 claim
Sudden cardiac arrest 1 claim
Temperature control after cardiac arrest 1 claim
Transcatheter aortic valve replacement (TAVR) 2 claims
Unequal bystander CPR after cardiac arrest in the community 1 claim
USPSTF 2021: screening for hypertension in adults 1 claim
USPSTF 2022: screening for atrial fibrillation 1 claim
WHO HEARTS technical package 2 claims
AF that causes no symptoms is hard to diagnose 1 claim
Alirocumab 1 claim
Amplatzer Septal Occluder 2 claims
Apixaban 1 claim
Apixaban (Eliquis) 1 claim
Atrial fibrillation (AF) 1 claim
Bempedoic acid 1 claim
BNP and NT-proBNP blood tests 1 claim
CardioMEMS HF System 2 claims
Colchicine 1 claim
CoreValve and Evolut transcatheter valves 4 claims
Coronary artery disease 1 claim
Dabigatran 1 claim
Dabigatran (Pradaxa) 1 claim
Dapagliflozin 4 claims
Dapagliflozin (Farxiga) 1 claim
Empagliflozin 4 claims
Empagliflozin (Jardiance) 1 claim
Estimated glomerular filtration rate (eGFR) 2 claims
Evolocumab 1 claim
Evolocumab (Repatha) 1 claim
Ezetimibe 1 claim
Finerenone 2 claims
Finerenone (Kerendia) 1 claim
HbA1c blood test 1 claim
Heart failure 2 claims
High LDL cholesterol 1 claim
Inclisiran (Leqvio) 1 claim
Irregular Rhythm Notification Feature (Apple) 1 claim
LEADER: liraglutide and cardiovascular events in type 2 diabetes 1 claim
Left ventricular ejection fraction (LVEF) 1 claim
Lipoprotein(a) 1 claim
Look AHEAD: intensive lifestyle intervention in type 2 diabetes 1 claim
Many people with HFrEF do not receive all recommended medicines at target doses 1 claim
Melody transcatheter pulmonary valve 3 claims
MitraClip 4 claims
Percutaneous coronary intervention (stents) 1 claim
Rheumatic heart disease 1 claim
Rheumatic heart disease burden where prevention and valve surgery are hard to reach 1 claim
Rhythm control for AF (medicines or catheter ablation) 1 claim
Rivaroxaban 1 claim
Rivaroxaban (Xarelto) 1 claim
Sacubitril/valsartan (Entresto) 1 claim
SAPIEN 3 transcatheter heart valve 2 claims
Semaglutide 2 claims
Semaglutide injection for diabetes (Ozempic) 1 claim
Semaglutide injection for weight management (Wegovy) 1 claim
SGLT2 inhibitors (drug class) 1 claim
Smartwatch irregular-pulse detection 1 claim
Start and step up heart-failure medicines quickly after a hospital stay 1 claim
Statins 1 claim
Tirzepatide 1 claim
Tirzepatide (Mounjaro) 1 claim
Transcatheter aortic valve replacement (TAVR) 4 claims
TriClip 2 claims
Type 2 diabetes 2 claims
Urine albumin-to-creatinine ratio (UACR) 1 claim
WATCHMAN left atrial appendage closure device 2 claims
Ambulatory blood pressure monitoring (ABPM) 1 claim
Automated upper-arm cuff blood pressure device 1 claim
Blood pressure 1 claim
Blood pressure lowering medicine 5 claims
Blood-pressure lowering to a target 3 claims
Cuffless blood pressure monitoring 2 claims
Home blood pressure monitoring 1 claim
Hypertension treatment by nonphysician professionals, such as pharmacists and nurses 1 claim
Omron HEM-907 blood pressure monitor 2 claims